Status:
UNKNOWN
Comparison of Video Laryngoscopy With Rigid Stylet vs Video Laryngoscopy With the TCI Articulating Introducer for Endotracheal Intubation in Simulated Difficult Airways
Lead Sponsor:
Tianjin Medical University General Hospital
Conditions:
Intubation; Difficult or Failed
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Purpose: To compare the efficacy and safety of TCI tube core and ordinary tube core assisted tracheal intubation in simulating difficult airway under visual laryngoscope, and to provide reference for...
Detailed Description
Endotracheal intubation plays an important role in contemporary clinical anesthesia. Direct laryngoscope intubation is the traditional intubation method in anesthesia and emergency medical work. Howev...
Eligibility Criteria
Inclusion
- Men ≥18 years of age or non-pregnant women;
- For elective gynecological surgery or upper abdominal surgery under general anesthesia by oral tracheal intubation, the operation position was supine and the operation time was less than 3 hours;
- Subject's American Society of Anesthesiologists physical status is I-III
- Subjects who could understand the purpose of the trial, voluntarily participated and signed the informed consent form, and were willing to accept the designated follow-up.
Exclusion
- any cerebrovascular accident, such as stroke, transient ischemic attack (TIA), etc. occurred within 3 months;
- patients with unstable angina pectoris or myocardial infarction within 3 months;
- laryngeal mass, obstruction, maxillofacial fracture or deformity;
- Full stomach, high intra-abdominal pressure, habitual vomiting, gastroesophageal reflux disease;
- pharyngeal infection, hematoma, abscess, tonsil enlargement;
- Upper respiratory tract infection within one month, fever, cough, runny nose, nasal congestion, etc.;
- history of chronic airway inflammation, airway hyperresponsiveness or asthma;
- diabetic patients with severe diabetic complications (diabetic ketoacidosis, hyperosmolar coma, various infections, macroangiopathy, diabetic nephropathy, retinopathy, diabetic cardiomyopathy, diabetic neuropathy, diabetic foot, etc.);
- severe complications of hypertension, such as arterial dissection, renal failure, cerebral hemorrhage, etc.;
- reoperation within 3 months;
- patients with contraindications or allergies to intraoperative drugs;
- patients enrolled in other studies within 30 days;
- poor adherence or the investigator's opinion that the patient was not suitable for the study.
Key Trial Info
Start Date :
November 1 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
July 1 2024
Estimated Enrollment :
240 Patients enrolled
Trial Details
Trial ID
NCT06115694
Start Date
November 1 2023
End Date
July 1 2024
Last Update
November 3 2023
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.